17.04.2020
- Germany’s CEVEC Pharmaceuticals and the UK’s Evox Therapeutics have signed a license agreement covering development and commercialization of therapeutic exosomes using CEVEC’s...
14.04.2020
- German drug discovery and technology company Evotec has established a dedicated site in Orth/Donau, Austria, for the research and development of gene therapy-based projects. The...
13.11.2019
- Germany’s Merck has signed a license agreement with Evotec, granting the Hamburg-based internationally active biotechnology group access to its CRISPR genome-editing technology...
26.09.2019
- German drug discovery and development company Evotec has entered into a strategic, multi-year collaboration with Japan’s Takeda Pharmaceutical that could be worth in excess of $850...
27.05.2019
- German drug discovery and development company Evotec has signed an agreement to buy Just Biotherapeutics, a US biologics company. Founded in 2014, Just Biotherapeutics is backed by...
15.03.2018
- Hamburg, Germany-based drug development specialist Evotec and French drugmaker Sanofi have entered into exclusive negotiations calling for Evotec to accelerate infectious disease...
04.10.2016
- Bayer and Evotec have signed a five-year multi-research pact to develop multiple clinical candidates to treat chronic kidney diseases. Both of the German companies will contribute...
